Immunoglobulin G Fc region binding polypeptide
View Patent ↗An immunoglobulin G Fc region binding polypeptide is provided, consisting of an amino acid sequence selected from i) a variant of Protein A domain or Protein Z and ii) an amino acid sequence which has at least 95% identity thereto. Also provided are methods for producing the polypeptide, compositions comprising the polypeptide, polynucleotides encoding the polypeptide, multimers of the polypeptide, and methods of using the polypeptide.
1. An immunoglobulin G Fc region binding polypeptide, comprising an mamino acid sequence:
i) X 1 -([spacer1]-(SEQ ID NO: 10)-X 17 LPX 20 -
(SEQ ID NO: 11)-X 36 -(SEQ ID NO: 12)-
X 51 -(SEQ ID NO: 13)-[spacer2]) n -C CTERM-1 X CTERM
wherein, independently of each other,
X 1 is P or nothing;
[spacer1] is an amino acid sequence consisting of 1-3 amino acid residues;
X 17 is any amino acid residue;
X 20 is any amino acid residue;
X 36 is any amino acid residue except for D;
X 51 is any amino acid residue;
[spacer2] is an amino acid sequence consisting of 0-20 amino acid residues;
X CTERM is D or nothing;
and n is 1-4.
2. The IgG Fc-binding polypeptide of claim 1 , wherein [spacer1] is selected from A, AE and AEA.
3. The IgG Fc-binding polypeptide of claim 2 , wherein [spacer1] is A.
4. The IgG Fc-binding polypeptide of claim 1 , wherein X 17 is H.
5. The IgG Fc-binding polypeptide of claim 1 , wherein X 20 is any amino acid residue except for N, for example T.
6. The IgG Fc-binding polypeptide of claim 1 , wherein X 20 is N.
7. The IgG Fc-binding polypeptide of claim 1 , wherein X 36 is selected from E and A.
8. The IgG Fc-binding polypeptide of claim 1 , wherein X 51 is any amino acid residue except for N.
9. The IgG Fc-binding polypeptide of claim 1 , wherein X 51 is N.
10. The IgG Fc-binding polypeptide of claim 1 , wherein all amino acid residues of [spacer2] are independently selected from A, E, F, G, I, K, L, P, Q, R, S, T and V.
11. The IgG Fc-binding polypeptide of claim 1 , wherein [spacer2] is G.
12. The IgG Fc-binding polypeptide of claim 1 , wherein n is 1.
13. The IgG Fc-binding polypeptide of claim 1 , wherein n is 2.
14. The IgG Fc-binding polypeptide of claim 1 , wherein n is 4.
15. The IgG Fc-binding polypeptide of claim 1 , which binds to IgG Fc such that the K D value of the interaction is at most 1×10 −6 M.
16. The IgG Fc-binding polypeptide of claim 15 , which binds to IgG Fc such that the K D value of the interaction is at most 1×10 −7 M.
17. The IgG Fc-binding polypeptide of claim 16 , which binds to IgG Fc such that the K D value of the interaction is at most 5×10 −8 M.
18. The IgG Fc-binding polypeptide of claim 1 , which is capable of binding to the Fc portion of a human IgG molecule.
19. The IgG Fc-binding polypeptide of claim 18 , which is capable of binding to classes 1, 2 and 4 of human IgG.
20. The IgG Fc-binding polypeptide of claim 1 , which is capable of binding to the interface between the CH2 and CH3 domains of IgG Fc.
21. The IgG Fc-binding polypeptide an amino acid sequence selected from SEQ ID NO:5-6.
22. The IgG Fc-binding polypeptide of claim 1 , in which X 1 is P and X CTERM is D.
23. An IgG Fc-binding polypeptide comprising an amino acid sequence selected from SEQ ID NO:1-4.
24. A polynucleotide comprising a nucleotide sequence encoding the polypeptide of claim 1 .
25. A multimer polypeptide comprising:
at least two subunits, each subunit being the polypeptide of claim 22 ; and
an N-terminal leader peptide comprising a D residue as the last residue thereof.
26. A polynucleotide comprising the nucleotide sequence encoding a multimer polypeptide of claim 25 .